Copyright Reports & Markets. All rights reserved.

Global Prostate Cancer Diagnostics Market Research Report 2012-2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Objectives of Research
      • 1.1.1 Definition
      • 1.1.2 Specifications
    • 1.2 Market Segment
      • 1.2.1 by Type
        • 1.2.1.1 Tumor Biomarker Tests
        • 1.2.1.2 Imaging
        • 1.2.1.3 Biopsy
        • 1.2.1.4 Others
      • 1.2.2 by Application
        • 1.2.2.1 < 55
        • 1.2.2.2 55-75
        • 1.2.2.3 > 75
      • 1.2.3 by Regions

    2 Industry Chain

    • 2.1 Industry Chain Structure
    • 2.2 Upstream
    • 2.3 Market
      • 2.3.1 SWOT
      • 2.3.2 Dynamics

    3 Environmental Analysis

    • 3.1 Policy
    • 3.2 Economic
    • 3.3 Technology
    • 3.4 Market Entry

    4 Market Segmentation by Type

    • 4.1 Market Size
      • 4.1.1 Tumor Biomarker Tests Market, 2013-2018
      • 4.1.2 Imaging Market, 2013-2018
      • 4.1.3 Biopsy Market, 2013-2018
      • 4.1.4 Others Market, 2013-2018
    • 4.2 Market Forecast
      • 4.2.1 Tumor Biomarker Tests Market Forecast, 2019-2024
      • 4.2.2 Imaging Market Forecast, 2019-2024
      • 4.2.3 Biopsy Market Forecast, 2019-2024
      • 4.2.4 Others Market Forecast, 2019-2024

    5 Market Segmentation by Application

    • 5.1 Market Size
      • 5.1.1 < 55 Market, 2013-2018
      • 5.1.2 55-75 Market, 2013-2018
      • 5.1.3 > 75 Market, 2013-2018
    • 5.2 Market Forecast
      • 5.2.1 < 55 Market Forecast, 2019-2024
      • 5.2.2 55-75 Market Forecast, 2019-2024
      • 5.2.3 > 75 Market Forecast, 2019-2024

    6 Market Segmentation by Region

    • 6.1 Market Size
      • 6.1.1 Asia-Pacific
        • 6.1.1.1 Asia-Pacific Market, 2012-2018
        • 6.1.1.2 Asia-Pacific Market by Type
        • 6.1.1.3 Asia-Pacific Market by Application
      • 6.1.2 North America
        • 6.1.2.1 North America Market, 2012-2018
        • 6.1.2.2 North America Market by Type
        • 6.1.2.3 North America Market by Application
      • 6.1.3 Europe
        • 6.1.3.1 Europe Market, 2012-2018
        • 6.1.3.2 Europe Market by Type
        • 6.1.3.3 Europe Market by Application
      • 6.1.4 South America
        • 6.1.4.1 South America Market, 2012-2018
        • 6.1.4.2 South America Market by Type
        • 6.1.4.3 South America Market by Application
      • 6.1.5 Middle East & Africa
        • 6.1.5.1 Middle East & Africa Market, 2012-2018
        • 6.1.5.2 Middle East & Africa Market by Type
        • 6.1.5.3 Middle East & Africa Market by Application
    • 6.2 Market Forecast
      • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
      • 6.2.2 North America Market Forecast, 2019-2024
      • 6.2.3 Europe Market Forecast, 2019-2024
      • 6.2.4 South America Market Forecast, 2019-2024
      • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

    7 Market Competitive

    • 7.1 Global Market by Vendors
    • 7.2 Market Concentration
    • 7.3 Price & Factors
    • 7.4 Marketing Channel

    8 Major Vendors

    • 8.1 Genomic Health
    • 8.2 Abbott
    • 8.3 OPKO
    • 8.4 Siemens Healthcare
    • 8.5 DiaSorin
    • 8.6 bioMeriux
    • 8.7 Roche
    • 8.8 MDx Health
    • 8.9 Beckman Coulter
    • 8.10 Myriad Genetics
    • 8.11 Ambry Genetics

    9 Conclusion

    Summary
    The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
    The global Prostate Cancer Diagnostics market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
    Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
    Tumor Biomarker Tests
    Imaging
    Biopsy
    Others
    Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
    Genomic Health
    Abbott
    OPKO
    Siemens Healthcare
    DiaSorin
    bioMeriux
    Roche
    MDx Health
    Beckman Coulter
    Myriad Genetics
    Ambry Genetics
    Based on Application, the report describes major application share of regional market. Application mentioned as follows:
    < 55
    55-75
    > 75
    Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa

    Buy now